Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
While the immune system is credited with averting tuberculosis in billions of individuals exposed to Mycobacterium tuberculosis , the immune system is also culpable for tempering the ability of antibiotics to deliver swift and durable cure of disease. In individuals afflicted with tuberculosis, host immunity produces diverse microenvironmental niches that support suboptimal growth, or complete growth arrest, of M. tuberculosis . The physiological state of nonreplication in bacteria is associated with phenotypic drug tolerance. Many of these host microenvironments, when modeled in vitro by carbon starvation, complete nutrient starvation, stationary phase, acidic pH, reactive nitrogen intermediates, hypoxia, biofilms, and withholding streptomycin from the streptomycin-addicted strain SS18b, render M. tuberculosis profoundly tolerant to many of the antibiotics that are given to tuberculosis patients in clinical settings. Targeting nonreplicating persisters is anticipated to reduce the duration of antibiotic treatment and rate of posttreatment relapse. Some promising drugs to treat tuberculosis, such as rifampin and bedaquiline, only kill nonreplicating M. tuberculosis in vitro at concentrations far greater than their minimal inhibitory concentrations against replicating bacilli. There is an urgent demand to identify which of the currently used antibiotics, and which of the molecules in academic and corporate screening collections, have potent bactericidal action on nonreplicating M. tuberculosis . With this goal, we review methods of high-throughput screening to target nonreplicating M. tuberculosis and methods to progress candidate molecules. A classification based on structures and putative targets of molecules that have been reported to kill nonreplicating M. tuberculosis revealed a rich diversity in pharmacophores.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“This suggests that the antimycobacterial members of these families may likewise be tailored to display the pharmacokinetic and pharmacodynamic properties and low toxicities that allowed approval of the family members in clinical use (177).”
BackgroundA Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Stochastic mRNA Synthesis in Mammalian Cells
Raj, A., Peskin, C. S., Tranchina, D., Vargas, D. Y., & Tyagi, S. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040309 · Cited by 1,737
Beyond oxidative stress: an immunologist's guide to reactive oxygen species
Nathan, C., & Cunningham-Bussel, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3423 · Cited by 1,619
Self-citationNathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469
Self-citationTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Self-citationBetts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395 · cited 4×
“However, metronidazole ’ s activity in animal models of tuberculosis correlated imperfectly with hypoxia in granulomas (Table 1) (12 – 19).”
BackgroundMethodInfluentialIdentification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Self-citationWayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141 · cited 5×
“Some investigators have assumed that failure to grow is syn-onymous with shutdown of the bacterial machinery that synthesizes macromolecules and that the lack of need for macromolecules explains the lack of sensitivity to drugs that inhibit their synthesis (30, 50 – 52, 95, 96).”
BackgroundMethodInfluentialIrreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Mycobacterial persistence requires the utilization of host cholesterol
Pandey, A. K., & Sassetti, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711159105 · Cited by 1,064
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025
Debnath, A. K., Lopez de Compadre, R. L., Debnath, G., Shusterman, A. J., & Hansch, C. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00106a046 · Cited by 868
The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts
Skaar, E. P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000949 · Cited by 796
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
MacMicking, J. D., Taylor, G. A., & McKinney, J. D. (2003) · Science · doi:10.1126/science.1088063 · Cited by 685
Noise in Gene Expression Determines Cell Fate in Bacillus subtilis
Maamar, H., Raj, A., & Dubnau, D. (2007) · Science · doi:10.1126/science.1140818 · Cited by 663
A Role for the ATP7A Copper-transporting ATPase in Macrophage Bactericidal Activity
White, C., Lee, J., Kambe, T., Fritsche, K., & Petris, M. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070201 · Cited by 524
Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
Aldridge, B. B., Fernandez-Suarez, M., Heller, D., Ambravaneswaran, V., Irimia, D., Toner, M., & Fortune, S. M. (2012) · Science · doi:10.1126/science.1216166 · Cited by 454 · cited 1×
“Mycobacterial asymmetric division results in differential antibiotic sensitivity of daughter cells (80, 81).”
BackgroundTuberculosis — metabolism and respiration in the absence of growth
Boshoff, H. I. M., & Barry, C. E. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1065 · Cited by 448 · cited 2×
“M. tuberculosis is not restricted to using oxygen as an electron acceptor; it can also use nitrate or fumarate (20 – 22).”
BackgroundVoskuil, M. I., Visconti, K. C., & Schoolnik, G. K. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.02.003 · Cited by 448 · cited 3×
“2-Substituted 4-hydroxyquinoline (compounds 44 and 45) inhibitors of triacylglycerol lipase LipY (encoded by rv3097c ) killed hypoxic M. tuberculosis (215).”
BackgroundA membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis
Vandal, O. H., Pierini, L. M., Schnappinger, D., Nathan, C. F., & Ehrt, S. (2008) · Nature Medicine · doi:10.1038/nm.1795 · Cited by 368 · cited 2×
“One strategy to identify molecules that kill nonrep-licating mycobacteria is to combine various stresses encountered by M. tuberculosis during infections of macrophages, animals, and humans (49, 53, 124, 229 – 245).”
BackgroundInfluentialSelf-citationDiarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
Koul, A., Vranckx, L., Dendouga, N., Balemans, W., Van den Wyngaert, I., Vergauwen, K., Göhlmann, H. W. H., Willebrords, R., Poncelet, A., Guillemont, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803899200 · Cited by 364
Dahl, J. L., Kraus, C. N., Boshoff, H. I. M., Doan, B., Foley, K., Avarbock, D., Kaplan, G., Mizrahi, V., Rubin, H., & Barry, C. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1631248100 · Cited by 349
Copper resistance is essential for virulence of Mycobacterium tuberculosis
Wolschendorf, F., Ackart, D., Shrestha, T. B., Hascall-Dove, L., Nolan, S., Lamichhane, G., Wang, Y., Bossmann, S. H., Basaraba, R. J., & Niederweis, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009261108 · Cited by 332
Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
Baek, S.-H., Li, A. H., & Sassetti, C. M. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001065 · Cited by 324
Gupta, R., Lavollay, M., Mainardi, J.-L., Arthur, M., Bishai, W. R., & Lamichhane, G. (2010) · Nature Medicine · doi:10.1038/nm.2120 · Cited by 281
Eoh, H., & Rhee, K. Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219375110 · Cited by 278 · cited 2×
“…is bactericidal to hypoxic mycobacteria, but this was only demonstrated under conditions in which no alternative electron acceptor was provided; killing was attenuated by inclusion of nitrate, a physiologic electron acceptor used by hypoxic M. tuberculosis and present in body fl uids (167, 168).”
BackgroundMethodFumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis
Watanabe, S., Zimmermann, M., Goodwin, M. B., Sauer, U., Barry, C. E., & Boshoff, H. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002287 · Cited by 246
Brook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237
Persister Cells: Molecular Mechanisms Related to Antibiotic Tolerance
Lewis, K. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-28951-4_8 · Cited by 217
Identification of a copper-binding metallothionein in pathogenic mycobacteria
Gold, B., Deng, H., Bryk, R., Vargas, D., Eliezer, D., Roberts, J., Jiang, X., & Nathan, C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.109 · Cited by 217 · cited 1×
“…library, erroneous dispensing of compounds, incorrect structure assignment, splashing of compounds between microtiter wells, compound degradation, and incomplete removal of reagents or catalysts used to synthesize the original compound, such as organotin, which can have antiseptic properties (140).”
BackgroundSelf-citationMechanisms of iron regulation in mycobacteria: role in physiology and virulence
Rodriguez, G. M., & Smith, I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03384.x · Cited by 162
Sarathy, J., Dartois, V., Dick, T., & Gengenbacher, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02202-12 · Cited by 148
Sambandamurthy, V. K., Derrick, S. C., Jalapathy, K. V., Chen, B., Russell, R. G., Morris, S. L., & Jacobs, W. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.1196-1203.2005 · Cited by 138
Differential Antibiotic Susceptibilities of Starved Mycobacterium tuberculosis Isolates
Xie, Z., Siddiqi, N., & Rubin, E. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4778-4780.2005 · Cited by 136 · cited 3×
“…are hypoxia (the Wayne model) and the low oxygen recovery assay (LORA) (29, 95, 96); carbon starvation (54, 121); nutrient starvation (12, 52); stationary phase (105); maintenance of intrabacterial pH under acidic culture conditions (119, 122 – 126); bio fi lms (102, 127 – 130); depleting…”
Background
Cited by
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Recent updates on drug resistance in Mycobacterium tuberculosis
Singh, R., Dwivedi, S. P., Gaharwar, U. S., Meena, R., Rajamani, P., & Prasad, T. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14478 · Cited by 337
Lee, J. J., Lee, S.-K., Song, N., Nathan, T. O., Swarts, B. M., Eum, S.-Y., Ehrt, S., Cho, S.-N., & Eoh, H. (2019) · Nature Communications · doi:10.1038/s41467-019-10975-7 · Cited by 122
Kumar, N., Sharma, S., & Kaushal, P. S. (2024) · Nature Communications · doi:10.1038/s41467-024-44879-y · Cited by 20
Metadata
- Authors
- Gold, B., & Nathan, C.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2017-02-24
- Volume
- 5
- Issue
- 1
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2605302163
- Cited by
- 131
- References
- 40
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.